The companies have an expansive clinical program for the mRNA neoantigen therapy intismeran autogene in combination with ...
A subcutaneously injected version of Merck cancer immunotherapy Keytruda is now FDA approved, a regulatory decision that gives patients a less burdensome dosing option and provides the pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results